Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells

被引:93
作者
Hua, Wen-Feng [1 ]
Fu, Yong-Shui [1 ,2 ]
Liao, Yi-Ji [1 ]
Xia, Wen-Jie [2 ]
Chen, Yang-Chao [3 ]
Zeng, Yi-Xin [1 ]
Kung, Hsiang-Fu [1 ,3 ]
Xie, Dan [1 ]
机构
[1] Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China
[2] Guangzhou Blood Ctr, Guangzhou 510095, Guangdong, Peoples R China
[3] Chinese Univ Hong Kong, State Key Lab Oncol S China, Hong Kong, Hong Kong, Peoples R China
关键词
Curcumin; EZH2; MAPK; Histone methyltransferase; Breast cancer; ZESTE HOMOLOG-2; PROTEIN; PROLIFERATION; INHIBITORS; APOPTOSIS; ACETYLTRANSFERASE; TRANSCRIPTION; METHYLATION; CARCINOMA; INVASION;
D O I
10.1016/j.ejphar.2010.03.051
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Curcumin, a natural compound isolated from turmeric, may inhibit cell proliferation in various tumor cells through a mechanism that is not fully understood. The enhancer of zeste homolog 2 (EZH2) gene is overexpressed in human breast cancers with poor prognosis. In this study, we observed a dose- and time-dependent down-regulation of expression of EZH2 by curcumin that correlates with decreased proliferation in the MDA-MB-435 breast cancer cell line. The curcumin treatment resulted in an accumulation of cells in the G(1) phase of the cell cycle. Further investigation revealed that curcumin-induced down-regulation of EZH2 through stimulation of three major members of the mitogen-activated protein kinase (MAPK) pathway: c-Jun NH2-terminal kinase (INK), extracellular signal-regulated kinase (ERK) and p38 kinase. These data suggest that an underlying mechanism of the MAPK pathway mediates the down-regulation of EZH2, thus contributing to the anti-proliferative effects of curcumin against breast cancer. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:16 / 21
页数:6
相关论文
共 27 条
[1]   RETRACTED: Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines (Retracted article. See vol. 102, pg. 147, 2016) [J].
Aggarwal, Bharat B. ;
Banerjee, Sanjeev ;
Bharadwaj, Uddalak ;
Sung, Bokyung ;
Shishodia, Shishir ;
Sethi, Gautam .
BIOCHEMICAL PHARMACOLOGY, 2007, 73 (07) :1024-1032
[2]   Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription [J].
Balasubramanyam, K ;
Varier, RA ;
Altaf, M ;
Swaminathan, V ;
Siddappa, NB ;
Ranga, U ;
Kundu, TK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (49) :51163-51171
[3]   Akt-mediated phsophorylationof EZH2 suppresses methylation of lysine 27 in histone H3 [J].
Cha, TL ;
Zhou, BHP ;
Xia, WY ;
Wu, YD ;
Yang, CC ;
Chen, CT ;
Ping, B ;
Otte, AP ;
Hung, MC .
SCIENCE, 2005, 310 (5746) :306-310
[4]   Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin [J].
Chen, Yangchao ;
Lin, Marie C. ;
Yao, Hong ;
Wang, Hua ;
Zhang, Ai-Qun ;
Yu, Jun ;
Hui, Chee-kin ;
Lau, George K. ;
He, Ming-liang ;
Sung, Joseph ;
Kung, Hsiang-fu .
HEPATOLOGY, 2007, 46 (01) :200-208
[5]   Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells [J].
Collett, GP ;
Campbell, FC .
CARCINOGENESIS, 2004, 25 (11) :2183-2189
[6]   Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer [J].
Collett, K ;
Eide, GE ;
Arnes, J ;
Stefansson, IM ;
Eide, J ;
Braaten, A ;
Aas, T ;
Otte, AP ;
Akslen, LA .
CLINICAL CANCER RESEARCH, 2006, 12 (04) :1168-1174
[7]  
Hong RL, 1999, CLIN CANCER RES, V5, P1884
[8]   Cancer statistics, 2008 [J].
Jemal, Ahmedin ;
Siegel, Rebecca ;
Ward, Elizabeth ;
Hao, Yongping ;
Xu, Jiaquan ;
Murray, Taylor ;
Thun, Michael J. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2008, 58 (02) :71-96
[9]   Curcumin Inhibition of Integrin (α6β4)-Dependent Breast Cancer Cell Motility and Invasion [J].
Kim, Hong Im ;
Huang, Huang ;
Cheepala, Satish ;
Huang, Shile ;
Chung, Jun .
CANCER PREVENTION RESEARCH, 2008, 1 (05) :385-391
[10]   Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27 [J].
Kirmizis, A ;
Bartley, SM ;
Kuzmichev, A ;
Margueron, R ;
Reinberg, D ;
Green, R ;
Farnham, PJ .
GENES & DEVELOPMENT, 2004, 18 (13) :1592-1605